INS and type 2 diabetes mellitus: Elevated levels of lipid metabolites such as DAGs and ceramides have been observed in skeletal muscle from obese and subjects with type 2 diabetes mellitus25,26, and it is proposed that ceramide, DAG and long-chain FA acyl-CoA may interfere with insulin signalling11,27,28.